| | On comparing cytokine levels in auranofin and DMSO-treated cells at 24 and 48 h, SARS-CoV-2-induced cytokines was found in significantly lower levels in auranofin treated cells. | ✍ | 32442105 (Virology)
| PMID | 32442105 Date of Publishing: 2020 Aug | | Title | The FDA-approved gold drug auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells | | Author(s) name | Rothan HA, Stone S et al. | | Journal | Virology | | Impact factor | 2.819 Citation count: 54 |
×
| NLM format |
| Rothan HA, Stone S, Natekar J, Kumari P, Arora K, Kumar M. The FDA-approved gold drug auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells. Virology. 2020 Aug;547:7-11. PMID:32442105 |
|